179 related articles for article (PubMed ID: 26241954)
1. Antipsychotic Maintenance Treatment: Time to Rethink?
Moncrieff J
PLoS Med; 2015 Aug; 12(8):e1001861. PubMed ID: 26241954
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
3. Choice of maintenance medication for schizophrenia.
Davis JM; Chen N
J Clin Psychiatry; 2003; 64 Suppl 16():24-33. PubMed ID: 14680416
[TBL] [Abstract][Full Text] [Related]
4. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
5. Is there rebound psychosis on withdrawal of antipsychotic medication in schizophrenia?
Taylor MJ; Yim S
Schizophr Res; 2018 Nov; 201():430-431. PubMed ID: 29887253
[No Abstract] [Full Text] [Related]
6. Switch or stay?
Davis JM; Marder SR; Tamminga CA
Am J Psychiatry; 2006 Dec; 163(12):2032-3. PubMed ID: 17151147
[No Abstract] [Full Text] [Related]
7. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
8. Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
Citrome L
CNS Spectr; 2012 Nov; 17 Suppl 1():1-9. PubMed ID: 23448847
[TBL] [Abstract][Full Text] [Related]
9. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Agid O; Foussias G; Remington G
Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
[TBL] [Abstract][Full Text] [Related]
10. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
11. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
[TBL] [Abstract][Full Text] [Related]
12. Medication-free minors with schizophrenia.
Cohen D
Am J Psychiatry; 2001 Feb; 158(2):324. PubMed ID: 11156827
[No Abstract] [Full Text] [Related]
13. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
Morrissette DA; Stahl SM
CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
16. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
17. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia.
Fleischhacker WW; Sanchez R; Johnson B; Jin N; Forbes RA; McQuade R; Baker RA; Carson W; Kane JM
Int Clin Psychopharmacol; 2013 Jul; 28(4):171-6. PubMed ID: 23615694
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment for lifetime disorders?
Greden JF; Tandon R
Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844
[No Abstract] [Full Text] [Related]
20. Methodological concerns in a trial of ziprasidone and olanzapine.
Ross DE
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
[No Abstract] [Full Text] [Related]
[Next] [New Search]